Home > Healthcare > Pharmaceuticals > Pharma Manufacturing > Cannabis Testing Market
Cannabis Testing Market size was valued at more than USD 7 billion in 2022 and is set to record lucrative growth at over 13.5% CAGR through 2032 attributed to the growing legalization of cannabis in several countries for medical purposes.
As marijuana usage becomes more recognized and legal in the United States, the Netherlands, South Africa, and other parts of the world, there is a rising demand for precise and reliable analysis of cannabis products. While several governments have approved the recreational use of cannabis, the number of cannabis testing facilities has increased. Moreover, several government institutions and business players are realizing the commercial and social significance of authorized medicinal cannabis, which is projected to boost market growth.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Cannabis Testing Market Size in 2022: | USD 7.4 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 13.6% |
2032 Value Projection: | USD 27.6 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 250 |
Tables, Charts & Figures: | 289 |
Segments covered: | Technology, Test, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|